No insider purchase over the last 90 days. The latest was filed 05 Nov 2025.
Every trade that managers of Cerenome, Inc. disclose to SEC (Form 4) is tracked on this page. The company is based in Austin. It was founded in 1996. 7 insiders have disclosed 20 filings since 18 October 2025.
Only purchases show up on the open market, 1 purchase in all worth €8,855, filed by 1 insider. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 finance chief. One trade stands out by size: a purchase of €8,855 from Sims Andrew John Hugh MacIntyre, disclosed on 5 November 2025.
The clock since the last published purchase (5 November 2025) now reads 347 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4.
Compared with its exchange (5,458 companies, median 22 filings), a count of 20 filings is below the norm. Looking back to 2016, when coverage begins, insiders filed 37 purchases and 2 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Headquarters: Austin · Founded: 1996
Source: Wikidata (CC0).
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 64 declarations
Cerenome, Inc. is a company listed on the XNAS market. It specializes in developing innovative solutions in the biotechnology sector.
Purchases our model currently ranks for the recommendations list.
All recommendations